Brande Monroe
Adult Health · Saint Louis, MONPI 1306254867
Payments from drug & device makers
Across 71 payments — averaging $24.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$343
- Lilly USA, LLC$246
- AstraZeneca$210
- Genentech USA, Inc.$140
- Sanofi$125
- GSK$89
- plus $570 from 16 others
What the payments were for
- Food & beverage$1,724100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 18 | $343 |
| Lilly USA, LLC | 14 | $246 |
| AstraZeneca | 8 | $210 |
| Genentech USA, Inc. | 1 | $140 |
| Sanofi | 1 | $125 |
| GSK | 1 | $89 |
| Pfizer | 4 | $69 |
| Edwards Lifesciences | 2 | $68 |
| Phathom Pharmaceuticals, Inc. | 3 | $50 |
| Exact Sciences | 2 | $50 |
| Novartis | 3 | $47 |
| Novo Nordisk | 3 | $46 |
| Medtronic | 2 | $43 |
| Axsome Therapeutics, Inc. | 1 | $30 |
| Actelion Pharmaceuticals US, Inc. | 1 | $26 |
| Boehringer Ingelheim | 1 | $25 |
| Johnson & Johnson | 1 | $23 |
| Vertex | 1 | $22 |
| Kyowa Kirin, Inc. | 1 | $21 |
| Bayer | 1 | $20 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $15 |
| Merck | 1 | $14 |
How this compares
$1,724 in reported general payments places this provider in the 70th percentile of 555 adult health providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 128 | $106,761 |
| MounjaroTirzepatide | 70 | $85,866 |
| FarxigaDapagliflozin Propanediol | 93 | $54,002 |
| Breo ElliptaFluticasone/Vilanterol | 65 | $36,447 |
| LinzessLinaclotide | 53 | $34,408 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 58 | $33,983 |
| JardianceEmpagliflozin | 30 | $27,256 |
| OzempicSemaglutide | 22 | $20,937 |
| Incruse ElliptaUmeclidinium Bromide | 33 | $18,987 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 29 | $18,132 |
| EliquisApixaban | 30 | $18,044 |
| SymbicortBudesonide/Formoterol Fumarate | 58 | $17,905 |
| Spiriva RespimatTiotropium Bromide | 26 | $17,038 |
| TradjentaLinagliptin | 26 | $15,791 |
| RybelsusSemaglutide | 16 | $15,036 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta, Incruse Ellipta, Arnuity Ellipta | $89 | $200,870298 claims |
| Lilly USA, LLCMounjaro, Trulicity | $246 | $99,49884 claims |
| AstraZenecaFarxiga, Breztri Aerosphere, Symbicort | $210 | $90,039180 claims |
| Boehringer IngelheimJardiance, Spiriva Respimat, Tradjenta | $25 | $60,08582 claims |
| Novo NordiskOzempic, Rybelsus | $46 | $35,97338 claims |
| AbbVieLinzess | $343 | $34,40853 claims |
| PfizerEliquis | $69 | $18,04430 claims |
| MerckJanuvia | $14 | $14,29326 claims |
| Johnson & JohnsonXarelto | $23 | $13,03513 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 555 adult health providers in Missouri.
Other adult health in Saint Louis
- Stephanie VogelSaint Louis$115K
- Shannon TuckerSaint Louis$93K
- Laurencia KlipfelSaint Louis$79K
- Maria WallsSaint Louis$69K
- Jennifer SpeiserSaint Louis$27K
- Michele NobsSaint Louis$15K
- Lisa Koester WiedemannSaint Louis$14K
- Erin DoserSaint Louis$13K
- Marcee StegemeierSaint Louis$12K
- Heather PophamSaint Louis$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.